Donor-Derived Epstein-Barr Virus Infection Among Pediatric Kidney Transplant Recipients

JAMA. 2025 Oct 28;334(16):1482-1484. doi: 10.1001/jama.2025.14067.

Vishnu S Potluri^{1

2

3}, Sandra Amaral^{3

4

5}, Chethan M Puttarajappa^{5

6}, Siqi Zhang², Kaitlin J Devine^{5

7}, Peter P Reese⁸, Elizabeth M Sonnenberg^{3

9}

¹ Renal-Electrolyte and Hypertension Division, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia.
² Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania Perelman School of Medicine, Philadelphia.
³ Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia.
⁴ Division of Nephrology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
⁵ Department of Pediatrics, University of Pennsylvania Perelman School of Medicine, Philadelphia.
⁶ Renal-Electrolyte Division, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
⁷ Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
⁸ Vanderbilt Center for Transplant Science, Vanderbilt University Medical Center, Nashville, Tennessee.
⁹ Department of Surgery, Hospital of the University of Pennsylvania, Philadelphia.

No abstract available

Plain language summary

This study uses US national data to examine Epstein-Barr virus–seronegative donor kidney use among Epstein-Barr virus–seronegative children.